This episode discusses three MMWR reports. The first report looks at safety monitoring of COVID-19 vaccine booster doses among people aged 12-17 years. The second report examines the effectiveness of the Pfizer-BioNTech vaccine in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among children and teens. And the last report highlights the increasing disparities in COVID-19 vaccination coverage between urban and rural counties.

This episode discusses nine MMWR reports. The first report looks at the effectiveness of mRNA COVID-19 vaccination among pregnant people against hospitalizations in infants younger than 6 months. The second report examines hospitalizations of children and teens with confirmed COVID-19. The next two reports look at changes in pediatric emergency department visits before and during the COVID-19 pandemic. The fifth report looks at safety monitoring of COVID-19 booster doses among adults. The sixth report examines waning effectiveness of two-dose and three-dose mRNA vaccines against emergency department and urgent care visits and hospitalizations during periods of Delta and Omicron predominance. The seventh report describes household spread of the Omicron variant. And the last two reports highlight the importance of following CDC's recommendations for wearing a well-fitting mask for 10 full days after showing symptoms or testing positive.

This episode discusses five MMWR reports. The first report looks at the effectiveness of masks in indoor settings for the prevention of COVID-19. The next report looks at the clinical characteristics and outcomes of adults hospitalized with COVID-19 during Omicron and Delta predominance. The third report examines COVID-19 infection and hospitalizations by vaccination status before and during Omicron. The fourth report describes vaccination coverage and vaccine confidence by sexual orientation and gender identity. And the last report looks at COVID-19 vaccination among New York adults living with diagnosed HIV.

This episode discusses two MMWR reports. The first report looks at trends in disease severity and health care utilization during the early Omicron variant period. And the second report looks at the effectiveness of a third dose of an mRNA vaccine in preventing COVID-19 hospitalization among adults with and without weakened immune systems.

This episode discusses six MMWR reports. The first report looks at racial and ethnic disparities in receipt of monoclonal antibodies for the treatment of COVID-19. The next three reports examine the protection provided by COVID-19 vaccines, including booster doses, during periods of Delta and Omicron variant emergence. The fifth report examines updated ACIP guidance for the use of Johnson & Johnson's Janssen COVID-19 vaccine. And the last report looks at early evidence of the Omicron variant in community wastewater.

This episode discusses four MMWR reports. The first report looks at the effectiveness of the Pfizer-BioNTech vaccine against multisystem inflammatory syndrome in children ages 12-17 years. The next report looks at the risk for newly diagnosed diabetes after COVID-19 infection among children. The third report examines COVID-19 vaccination during pregnancy and its association with preterm or small-for-gestational-age at birth. And the last report describes severe COVID-19 outcomes among people ages 18 years and older who have completed their primary vaccination series.

This episode discusses four MMWR reports. This first report looks at an Omicron variant cluster among a single household in Nebraska. The next report looks at vaccine safety in children ages 5-11 years. The third report examines the effectiveness of the Pfizer-BioNTech vaccine in preventing infection among adolescents ages 12-17 years. And the last report describes the characteristics and clinical outcomes in children and adolescents hospitalized with COVID-19.

This episode discusses five MMWR reports. This first report looks at the impact of a health care provider recommendation on vaccination status and attitudes among adults. The next two reports explore a testing strategy among k-12 schools in Los Angeles County, California and Lake County, Illinois. And the last two describe cases of a rare fungal infection reported by clinicians in Honduras and Arkansas during surges in Delta variant cases.

This episode discusses four MMWR reports. This first report looks at the U.S. response to the Omicron variant. The second highlights receipt of booster doses among adults ages 65 years and older. The third looks at the effectiveness of Pfizer-BioNTech and Moderna mRNA vaccines in preventing COVID-19-associated hospitalizations among older veterans. And the fourth report highlights vaccination rates among people experiencing homelessness.

This episode discusses six MMWR reports. The first two emphasize the risks associated with COVID-19 during pregnancy. The third report looks at infection rates, hospitalizations, and deaths among members of a large heath system. The fourth looks at health care access and use among adults with diabetes during COVID-19. The fifth report explores the impact surges in COVID-19 cases have on hospital systems. And the sixth report looks at the use of digital notification to provide timely outreach to people with COVID-19.